FDA panel recommends Pfizer’s low-dose Covid vaccine for kids ages 5 to 11

3 months ago·Washington, United States

Articles

General Summary

A key Food and Drug Administration advisory committee on Tuesday recommended a lower dose of Pfizer and BioNTech’s Covid-19 vaccine for children ages 5 to 11, a critical step in getting some 28 million more kids in the U.S. protected against the virus as the delta variant spreads.

Summary by Ground News

Yahoo News

FDA advisers back Pfizer’s COVID-19 vaccine for young kids

A panel of U.S. health advisers on Tuesday endorsed kid-size doses of Pfizer's COVID-19 vaccine, moving the U.S. closer to beginning vaccinations in children ages 5 to 11. A Food and Drug Administration advisory panel voted unanimously with one abstention that the vaccine's benefits in preventing COVID-19 in that age group outweigh any potential risks — including a heart-related side effect that's been very rare in teens and young adults who get…

3 months ago·Los Angeles, United States

Ownership:Verizon Communications

CBC News

FDA advisory committee recommends authorizing Pfizer's COVID vaccine for kids

The U.S. Food and Drug Administration isn't bound by the committee's recommendation, but is expected to consider it and make a decision in the coming days on whether to approve the vaccine for kids five to 11 years old.

3 months ago·Canada

Ownership:Canadian Broadcasting Corporation

Reuters

U.S. FDA advisers back Pfizer/BioNTech COVID-19 vaccine for children

An expert panel on Tuesday voted overwhelmingly to recommend the U.S. Food and Drug Administration authorize the Pfizer Inc and BioNTech SE COVID-19 vaccine for children ages 5 to 11, saying the benefits of inoculation outweigh the risks.

3 months ago·United Kingdom

Ownership:The Woodbridge Company

News18 India

U.S. FDA Advisers Back Pfizer/BioNTech COVID-19 Vaccine For Children

An expert panel on Tuesday voted overwhelmingly to recommend the U.S. Food and Drug Administration authorize the Pfizer Inc and BioNTech SE COVID19 vaccine for children ages 5 to 11, saying the benefits of inoculation outweigh the risks.

3 months ago·India

Ownership:Dhirubhai Ambani

CTV News

U.S. FDA advisers back Pfizer's COVID-19 vaccine for young kids

The U.S. moved a step closer to expanding COVID-19 vaccinations for millions more children as government advisers on Tuesday endorsed kid-size doses of Pfizer's shots for 5- to 11-year-olds.

3 months ago·Toronto, Canada

Ownership:BCE Inc.

The Hindu

U.S. FDA panel backs Pfizer’s low-dose COVID-19 vaccine for children

A Food and Drug Administration advisory panel voted unanimously, that the vaccine’s benefits in preventing COVID-19 in the 5-11 age group outweigh any potential risks.

3 months ago·India

Ownership:The Hindu Group